India wildlife trade is facing renewed scrutiny after five baby orangutans were found in an Odisha plantation in September 2026, prompting Indonesia to seek their return and drawing attention to controls on exotic animal imports.

Key Takeaways

  • Indonesia is sending experts to verify the five orangutans’ origins and assess their health.
  • India imported 41 orangutans between 2021 and 2024, according to CITES trade data.
  • A private wildlife facility disputed an expert’s allegation about one orangutan’s import and said its earlier chain of custody remained to be clarified.

India wildlife trade and gaps in oversight

Villagers found the three male and two female orangutans, aged six to eight months, in a casuarina forest in eastern India. The animals, whose native range is limited to Borneo and Sumatra, are now at an Indian zoo.

Indonesia’s Ministry of Forestry said it was taking active steps to bring the five animals home. It is sending experts to establish their origins and check their health.

Wildlife trafficking researcher Uttara Mendiratta said wealthy collectors’ demand for rare animals has helped drive trade from Southeast Asia. A 2026 study by National University of Singapore researchers estimated the global illegal wildlife trade at $34 billion a year.

India allowed owners to register exotic animals in 2020 without proving their origins. Mendiratta said limited inspection resources and expertise leave room for trafficked animals to be presented as registered ones. A 2022 tightening of wildlife laws gave authorities clearer powers to seize illegally traded exotic animals and prosecute traffickers.

Questions over imports at Vantara

Most commercial trade in orangutans is banned, although exceptions exist for captive-bred animals. India imported 41 orangutans from 2021 through 2024, according to CITES, the treaty governing trade in endangered wildlife. Sinan Serhadli of Indonesia’s Orangutan Information Centre questioned whether the animals were legitimately bred in captivity. The CITES Secretariat said the matter was under review and declined to comment.

Vantara, a private wildlife facility run by billionaire Mukesh Ambani’s family, has faced scrutiny over its animal acquisitions. In September 2026, 27 conservation and animal welfare organizations urged the facility to end wild animal imports. India’s Supreme Court cleared Vantara of wildlife trafficking and animal mistreatment allegations in 2025.

Vantara’s 2024–25 inventory lists a Tapanuli orangutan, a species found in a small area of Sumatra. CITES trade data shows the animal left Indonesia in 2024 and reached India through the United Arab Emirates. Serhadli said the transfer could not have happened legally. Vantara disputed that, saying the animal was legally imported into India while its prior chain of custody remained to be clarified with the UAE.

Indonesia’s Forestry Ministry said it could not confirm the animal’s species, origins or route to India. It said an investigation would require permit and transfer records as well as scientific testing.

Earlier orangutan returned to Indonesia

A separate orangutan was returned to Indonesia on October 19, 2026, after 19 months at Vantara. Officials had ordered its transfer from a public zoo because of concerns over its care, and it was treated for a respiratory infection and pneumonia.

A federal wildlife official wrote that India’s federal wildlife officials and CITES authority had not been informed of the transfer to Vantara. The facility said it supported the subsequent return and worked with relevant authorities to facilitate it.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.